Research ArticleAccepted Article
Safety and efficacy of intravenous golimumab in adults with ankylosing spondylitis: Results through 1 year of the GO-ALIVE study
John D. Reveille, Atul Deodhar, Paul H. Caldron, Anna Dudek, Diane D. Harrison, Lilianne Kim, Kim Hung Lo, Jocelyn H. Leu and Elizabeth C. Hsia
The Journal of Rheumatology March 2019, jrheum.180718; DOI: https://doi.org/10.3899/jrheum.180718
John D. Reveille
From the University of Texas McGovern Medical School, Houston, TX, USA; Oregon Health & Science University, Portland, OR, USA; Arizona Arthritis and Rheumatology Associates, Phoenix, AZ, USA; AMED Medical Center, Warsaw, Poland; Janssen Research & Development, LLC, Spring House, PA, USA; University of Pennsylvania, Philadelphia, PA, USA. Funding: This study was funded by Janssen Research & Development, LLC. Drs. Caldron, and Dudek served as trial investigators for Janssen; Dr. Reveille has received consultancies from Eli Lilly, Janssen, Novartis, Pfizer, and UCB and has served as a trial investigator for Janssen and Eli Lilly; Dr. Deodhar has received consultancies, speaking fees, and/or honoraria from AbbVie, BMS, Eli Lilly, Janssen, Novartis, Pfizer, and UCB; Drs. Harrison, Hsia, Kim, Lo, and Leu are or were employees of Janssen Research & Development, LLC at the time this work was performed, and own stock in Johnson & Johnson, of which Janssen Research & Development, LLC, is a wholly owned subsidiary. Address correspondence to: Elizabeth C Hsia, MD, MSCE Janssen Research & Development, LLC. 1400 McKean Rd PO Box 776 Spring House, PA 19477, E-mail: ehsia@its.jnj.com
Atul Deodhar
From the University of Texas McGovern Medical School, Houston, TX, USA; Oregon Health & Science University, Portland, OR, USA; Arizona Arthritis and Rheumatology Associates, Phoenix, AZ, USA; AMED Medical Center, Warsaw, Poland; Janssen Research & Development, LLC, Spring House, PA, USA; University of Pennsylvania, Philadelphia, PA, USA. Funding: This study was funded by Janssen Research & Development, LLC. Drs. Caldron, and Dudek served as trial investigators for Janssen; Dr. Reveille has received consultancies from Eli Lilly, Janssen, Novartis, Pfizer, and UCB and has served as a trial investigator for Janssen and Eli Lilly; Dr. Deodhar has received consultancies, speaking fees, and/or honoraria from AbbVie, BMS, Eli Lilly, Janssen, Novartis, Pfizer, and UCB; Drs. Harrison, Hsia, Kim, Lo, and Leu are or were employees of Janssen Research & Development, LLC at the time this work was performed, and own stock in Johnson & Johnson, of which Janssen Research & Development, LLC, is a wholly owned subsidiary. Address correspondence to: Elizabeth C Hsia, MD, MSCE Janssen Research & Development, LLC. 1400 McKean Rd PO Box 776 Spring House, PA 19477, E-mail: ehsia@its.jnj.com
Paul H. Caldron
From the University of Texas McGovern Medical School, Houston, TX, USA; Oregon Health & Science University, Portland, OR, USA; Arizona Arthritis and Rheumatology Associates, Phoenix, AZ, USA; AMED Medical Center, Warsaw, Poland; Janssen Research & Development, LLC, Spring House, PA, USA; University of Pennsylvania, Philadelphia, PA, USA. Funding: This study was funded by Janssen Research & Development, LLC. Drs. Caldron, and Dudek served as trial investigators for Janssen; Dr. Reveille has received consultancies from Eli Lilly, Janssen, Novartis, Pfizer, and UCB and has served as a trial investigator for Janssen and Eli Lilly; Dr. Deodhar has received consultancies, speaking fees, and/or honoraria from AbbVie, BMS, Eli Lilly, Janssen, Novartis, Pfizer, and UCB; Drs. Harrison, Hsia, Kim, Lo, and Leu are or were employees of Janssen Research & Development, LLC at the time this work was performed, and own stock in Johnson & Johnson, of which Janssen Research & Development, LLC, is a wholly owned subsidiary. Address correspondence to: Elizabeth C Hsia, MD, MSCE Janssen Research & Development, LLC. 1400 McKean Rd PO Box 776 Spring House, PA 19477, E-mail: ehsia@its.jnj.com
Anna Dudek
From the University of Texas McGovern Medical School, Houston, TX, USA; Oregon Health & Science University, Portland, OR, USA; Arizona Arthritis and Rheumatology Associates, Phoenix, AZ, USA; AMED Medical Center, Warsaw, Poland; Janssen Research & Development, LLC, Spring House, PA, USA; University of Pennsylvania, Philadelphia, PA, USA. Funding: This study was funded by Janssen Research & Development, LLC. Drs. Caldron, and Dudek served as trial investigators for Janssen; Dr. Reveille has received consultancies from Eli Lilly, Janssen, Novartis, Pfizer, and UCB and has served as a trial investigator for Janssen and Eli Lilly; Dr. Deodhar has received consultancies, speaking fees, and/or honoraria from AbbVie, BMS, Eli Lilly, Janssen, Novartis, Pfizer, and UCB; Drs. Harrison, Hsia, Kim, Lo, and Leu are or were employees of Janssen Research & Development, LLC at the time this work was performed, and own stock in Johnson & Johnson, of which Janssen Research & Development, LLC, is a wholly owned subsidiary. Address correspondence to: Elizabeth C Hsia, MD, MSCE Janssen Research & Development, LLC. 1400 McKean Rd PO Box 776 Spring House, PA 19477, E-mail: ehsia@its.jnj.com
Diane D. Harrison
From the University of Texas McGovern Medical School, Houston, TX, USA; Oregon Health & Science University, Portland, OR, USA; Arizona Arthritis and Rheumatology Associates, Phoenix, AZ, USA; AMED Medical Center, Warsaw, Poland; Janssen Research & Development, LLC, Spring House, PA, USA; University of Pennsylvania, Philadelphia, PA, USA. Funding: This study was funded by Janssen Research & Development, LLC. Drs. Caldron, and Dudek served as trial investigators for Janssen; Dr. Reveille has received consultancies from Eli Lilly, Janssen, Novartis, Pfizer, and UCB and has served as a trial investigator for Janssen and Eli Lilly; Dr. Deodhar has received consultancies, speaking fees, and/or honoraria from AbbVie, BMS, Eli Lilly, Janssen, Novartis, Pfizer, and UCB; Drs. Harrison, Hsia, Kim, Lo, and Leu are or were employees of Janssen Research & Development, LLC at the time this work was performed, and own stock in Johnson & Johnson, of which Janssen Research & Development, LLC, is a wholly owned subsidiary. Address correspondence to: Elizabeth C Hsia, MD, MSCE Janssen Research & Development, LLC. 1400 McKean Rd PO Box 776 Spring House, PA 19477, E-mail: ehsia@its.jnj.com
Lilianne Kim
From the University of Texas McGovern Medical School, Houston, TX, USA; Oregon Health & Science University, Portland, OR, USA; Arizona Arthritis and Rheumatology Associates, Phoenix, AZ, USA; AMED Medical Center, Warsaw, Poland; Janssen Research & Development, LLC, Spring House, PA, USA; University of Pennsylvania, Philadelphia, PA, USA. Funding: This study was funded by Janssen Research & Development, LLC. Drs. Caldron, and Dudek served as trial investigators for Janssen; Dr. Reveille has received consultancies from Eli Lilly, Janssen, Novartis, Pfizer, and UCB and has served as a trial investigator for Janssen and Eli Lilly; Dr. Deodhar has received consultancies, speaking fees, and/or honoraria from AbbVie, BMS, Eli Lilly, Janssen, Novartis, Pfizer, and UCB; Drs. Harrison, Hsia, Kim, Lo, and Leu are or were employees of Janssen Research & Development, LLC at the time this work was performed, and own stock in Johnson & Johnson, of which Janssen Research & Development, LLC, is a wholly owned subsidiary. Address correspondence to: Elizabeth C Hsia, MD, MSCE Janssen Research & Development, LLC. 1400 McKean Rd PO Box 776 Spring House, PA 19477, E-mail: ehsia@its.jnj.com
Kim Hung Lo
From the University of Texas McGovern Medical School, Houston, TX, USA; Oregon Health & Science University, Portland, OR, USA; Arizona Arthritis and Rheumatology Associates, Phoenix, AZ, USA; AMED Medical Center, Warsaw, Poland; Janssen Research & Development, LLC, Spring House, PA, USA; University of Pennsylvania, Philadelphia, PA, USA. Funding: This study was funded by Janssen Research & Development, LLC. Drs. Caldron, and Dudek served as trial investigators for Janssen; Dr. Reveille has received consultancies from Eli Lilly, Janssen, Novartis, Pfizer, and UCB and has served as a trial investigator for Janssen and Eli Lilly; Dr. Deodhar has received consultancies, speaking fees, and/or honoraria from AbbVie, BMS, Eli Lilly, Janssen, Novartis, Pfizer, and UCB; Drs. Harrison, Hsia, Kim, Lo, and Leu are or were employees of Janssen Research & Development, LLC at the time this work was performed, and own stock in Johnson & Johnson, of which Janssen Research & Development, LLC, is a wholly owned subsidiary. Address correspondence to: Elizabeth C Hsia, MD, MSCE Janssen Research & Development, LLC. 1400 McKean Rd PO Box 776 Spring House, PA 19477, E-mail: ehsia@its.jnj.com
Jocelyn H. Leu
From the University of Texas McGovern Medical School, Houston, TX, USA; Oregon Health & Science University, Portland, OR, USA; Arizona Arthritis and Rheumatology Associates, Phoenix, AZ, USA; AMED Medical Center, Warsaw, Poland; Janssen Research & Development, LLC, Spring House, PA, USA; University of Pennsylvania, Philadelphia, PA, USA. Funding: This study was funded by Janssen Research & Development, LLC. Drs. Caldron, and Dudek served as trial investigators for Janssen; Dr. Reveille has received consultancies from Eli Lilly, Janssen, Novartis, Pfizer, and UCB and has served as a trial investigator for Janssen and Eli Lilly; Dr. Deodhar has received consultancies, speaking fees, and/or honoraria from AbbVie, BMS, Eli Lilly, Janssen, Novartis, Pfizer, and UCB; Drs. Harrison, Hsia, Kim, Lo, and Leu are or were employees of Janssen Research & Development, LLC at the time this work was performed, and own stock in Johnson & Johnson, of which Janssen Research & Development, LLC, is a wholly owned subsidiary. Address correspondence to: Elizabeth C Hsia, MD, MSCE Janssen Research & Development, LLC. 1400 McKean Rd PO Box 776 Spring House, PA 19477, E-mail: ehsia@its.jnj.com
Elizabeth C. Hsia
From the University of Texas McGovern Medical School, Houston, TX, USA; Oregon Health & Science University, Portland, OR, USA; Arizona Arthritis and Rheumatology Associates, Phoenix, AZ, USA; AMED Medical Center, Warsaw, Poland; Janssen Research & Development, LLC, Spring House, PA, USA; University of Pennsylvania, Philadelphia, PA, USA. Funding: This study was funded by Janssen Research & Development, LLC. Drs. Caldron, and Dudek served as trial investigators for Janssen; Dr. Reveille has received consultancies from Eli Lilly, Janssen, Novartis, Pfizer, and UCB and has served as a trial investigator for Janssen and Eli Lilly; Dr. Deodhar has received consultancies, speaking fees, and/or honoraria from AbbVie, BMS, Eli Lilly, Janssen, Novartis, Pfizer, and UCB; Drs. Harrison, Hsia, Kim, Lo, and Leu are or were employees of Janssen Research & Development, LLC at the time this work was performed, and own stock in Johnson & Johnson, of which Janssen Research & Development, LLC, is a wholly owned subsidiary. Address correspondence to: Elizabeth C Hsia, MD, MSCE Janssen Research & Development, LLC. 1400 McKean Rd PO Box 776 Spring House, PA 19477, E-mail: ehsia@its.jnj.com
Published eLetters
eLetters are comments published online only and are not peer-reviewed. Publication of eLetter submissions is not guaranteed, and all submissions are reviewed and edited at the discretion of The Journal's staff.
If you wish to publish Letters to the Editor or Correspondence, please submit through our online submission system ScholarOne Manuscripts.
Jump to comment:
No eLetters have been published for this article.
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
Accepted manuscript
Safety and efficacy of intravenous golimumab in adults with ankylosing spondylitis: Results through 1 year of the GO-ALIVE study
John D. Reveille, Atul Deodhar, Paul H. Caldron, Anna Dudek, Diane D. Harrison, Lilianne Kim, Kim Hung Lo, Jocelyn H. Leu, Elizabeth C. Hsia
The Journal of Rheumatology Mar 2019, jrheum.180718; DOI: 10.3899/jrheum.180718
Accepted manuscript
Safety and efficacy of intravenous golimumab in adults with ankylosing spondylitis: Results through 1 year of the GO-ALIVE study
John D. Reveille, Atul Deodhar, Paul H. Caldron, Anna Dudek, Diane D. Harrison, Lilianne Kim, Kim Hung Lo, Jocelyn H. Leu, Elizabeth C. Hsia
The Journal of Rheumatology Mar 2019, jrheum.180718; DOI: 10.3899/jrheum.180718